Jeffrey D. Hartgerink, Ph.D.

The development of a new fabrication process to create aligned nanofiber hydrogels could offer new possibilities for tissue regeneration after injury and provide a way to test therapeutic drug candidates without the use of animals.

Jeffrey Hartgerink, professor of chemistry and bioengineering at Rice University and colleagues, developed peptide-based hydrogels that mimic the aligned structure of muscle and nerve tissues. Alignment is critical for the tissues’ functionality, but it is a challenging feature to reproduce in the lab, as it entails lining up individual cells… Continue reading.

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Jeffrey D. Hartgerink, Ph.D., Professor of Chemistry and Bioengineering, Chemistry and Bioengineering, Rice University, to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Dr. Hartgerink was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions to the area of peptide-based, nanostructured materials, which have tremendous potential for a variety of biomedical applications.“